Excellent news.
I am, overall, with a few exceptions, very very happy with how Argenica is progressing and what they've achieved.
Anybody who has been in the biotech space longer than 5 minutes KNOWS that delays almost always happen (some within the company's control, some from outside) although getting to the milestones and passing them is what's ultimately important. AGN hit an important milestone today and will hopefully hit another important milestone in around a month from now.
IF ethics approval is given and the company performs well in their Phase 1 trial, demonstrating safety, I believe we are grossly undervalued.
Ann: Ethics Application Submitted for Phase 1 Trial, page-3
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
80.0¢ |
Change
0.030(3.90%) |
Mkt cap ! $98.96M | |||
| Open | High | Low | Value | Volume |
| 79.5¢ | 81.5¢ | 79.5¢ | $30.31K | 37.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3409 | 80.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 81.5¢ | 4517 | 1 |
View Market Depth
| Last trade - 15.47pm 31/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |